Gut Microbiome Dysbiosis in Sepsis-induced Coagulopathy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-15

Study Completion Date

2021-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the diagnosis and treatment of patients with sepsis, through routine stool testing and dynamic testing of coagulation function, we found that patients often have stools that are not formed, the proportion of main fecal bacteria is imbalanced, the level of blood bacterial toxins rises, and the abnormal coagulation status indicate the gut microbiome dysbiosis may play an important regulatory role in abnormal blood coagulation in patients with sepsis. Therefore, we propose that the gut microbiome dysbiosis is involved in sepsis-induced coagulopathy. This project intends to prospectively observe the changes in gut microbiome dysbiosis and blood coagulation function in patients with sepsis before and after treatment, and explore whether the changes in gut microbiome dysbiosis promote the development of sepsis through coagulation disorders, provide new research perspectives for diagnosis and treatment for sepsis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

the Effect of Gut Microbiota on the Prognosis of Sepsis

NCT02768324

Sepsis

UNKNOWN

Study of Biomarkers in Patients of Sepsis Complicated With Gastrointestinal Dysfunction

NCT04647201

Sepsis Gastrointestinal Dysfunction

UNKNOWN

Nasal and Gut Microbiota Combined Clinical Events Predicts the Prognosis of Septic Patients

NCT05143736

Sepsis Septic Shock

RECRUITING

Effect of Immunophenotype on Prognosis of Sepsis

NCT05602584

Sepsis Septic Shock Sepsis Syndrome

UNKNOWN

Comparison the Value of Several Biomarkers of Sepsis

NCT01388725

Systemic Inflammatory Response Syndrome Sepsis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years and ≤85 years
* Sign the informed consent form
* Expected ICU hospital stay\> 24 hours
* △SOFA score ≥2 and confirmed or suspected infection

Exclusion Criteria

* Pregnant or breastfeeding women
* Estimated survival time \<24 hours
* Diagnosis of sepsis time\> 24 hours
* The length of ICU stay before diagnosis of sepsis\> 7 days
* Sepsis from which the source of infection cannot be determined
* Congenital coagulopathy

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No